"The UC San Diego Department of Ophthalmology at the Shiley Eye Institute is the only academic eye center in the region offering the most advanced treatments across all areas of eye care. Our world class clinicians, surgeons, scientists and staff are dedicated to excellence, and providing the best possible patient care to prevent, treat and cure eye diseases. Our research is at the forefront of developing new methods for diagnosis and treatments of eye diseases and disorders. In addition to educating the leaders of tomorrow, we are committed to serving the San Diego and global community."

During the past decade, UCSD Shiley Eye Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 9 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSD Shiley Eye Center" #1 sponsor was "University of California, San Diego" with 6 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "Glaukos Corporation" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Carl Zeiss Meditec, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSD Shiley Eye Center" #1 collaborator was "Bausch & Lomb Incorporated" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator and "Johns Hopkins University" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "UCSD Shiley Eye Center" are "Cytomegalovirus Retinitis" (4 trials), "HIV Infections" (4 trials), "Geographic Atrophy" (2 trials), "Glaucoma" (2 trials) and "Age Related Macular Degeneration" (1 trials). Many other conditions were trialed in "UCSD Shiley Eye Center" in a lesser frequency.

Most popular intervention types in "UCSD Shiley Eye Center" are "Drug" (14 trials), "Device" (4 trials), "Dietary Supplement" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Foscarnet sodium" (2 trials), "Ganciclovir" (2 trials), "Lampalizumab" (2 trials), "UVA Irradiation" (2 trials) and "riboflavin ophthalmic solution" (2 trials). Other intervention names were less common.

The vast majority of trials in "UCSD Shiley Eye Center" are 21 trials for "All" genders.

Currently, there are NaN active trials in "UCSD Shiley Eye Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in UCSD Shiley Eye Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UCSD Shiley Eye Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".